We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+14.21%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$987M
AUM Growth
+$120M
Cap. Flow
+$63.5M
Cap. Flow %
6.44%
Top 10 Hldgs %
5.22%
Holding
1,870
New
579
Increased
363
Reduced
419
Closed
480

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$6.71M
2
DXCM icon
DexCom
DXCM
+$6.59M
3
X
US Steel
X
+$6.1M
4
CMBT
CMB.TECH NV
CMBT
+$5.09M
5
SPLK
Splunk Inc
SPLK
+$4.85M

Top Sells

Rank Stock Value
1
GOOS
Canada Goose Holdings
GOOS
+$21.9M
2
STZ icon
Constellation Brands
STZ
+$9.52M
3
LUMN icon
Lumen
LUMN
+$7.13M
4
WY icon
Weyerhaeuser
WY
+$6.3M
5
FDX icon
FedEx
FDX
+$6.07M

Sector Composition

Rank Sector Weight
1 Healthcare 16.75%
2 Technology 15.19%
3 Consumer Discretionary 13.45%
4 Industrials 12.06%
5 Financials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EAT icon
176
Brinker International
EAT
$9.47B
$1.29M 0.13%
29,104
+10,404
+56% +$469K
MAS icon
177
Masco
MAS
$15.1B
$1.29M 0.13%
+32,713
New +$1.17M
HPP
178
Hudson Pacific Properties
HPP
$764M
$1.28M 0.13%
+5,326
New +$1.21M
TDC icon
179
Teradata
TDC
$3.15B
$1.28M 0.13%
+29,343
New +$1.32M
MHK icon
180
Mohawk Industries
MHK
$9.16B
$1.28M 0.13%
+10,149
New +$1.32M
ARWR icon
181
Arrowhead Research
ARWR
$12.5B
$1.28M 0.13%
69,613
+49,396
+244% +$815K
CCXI
182
DELISTED
ChemoCentryx, Inc.
CCXI
$1.27M 0.13%
91,400
-16,400
-15% -$188K
FLWS icon
183
1-800-Flowers.com
FLWS
$265M
$1.27M 0.13%
69,489
+26,220
+61% +$422K
NOC icon
184
Northrop Grumman
NOC
$78.3B
$1.27M 0.13%
+4,697
New +$1.28M
FN icon
185
Fabrinet
FN
$19.1B
$1.26M 0.13%
+24,160
New +$1.32M
NVDA icon
186
NVIDIA
NVDA
$5.11T
$1.26M 0.13%
281,440
+6,440
+2% +$25K
OFIX icon
187
Orthofix Medical
OFIX
$492M
$1.26M 0.13%
22,370
+2,927
+15% +$164K
TXT icon
188
Textron
TXT
$15.3B
$1.26M 0.13%
24,905
+17,541
+238% +$905K
SRDX
189
DELISTED
Surmodics
SRDX
$1.25M 0.13%
28,816
-1,559
-5% -$79.4K
MANH icon
190
Manhattan Associates
MANH
$11.1B
$1.25M 0.13%
22,640
-13,657
-38% -$699K
GMED icon
191
Globus Medical
GMED
$11B
$1.24M 0.13%
25,095
-2,302
-8% -$104K
EPC icon
192
Edgewell Personal Care
EPC
$1.3B
$1.24M 0.13%
+28,216
New +$1.18M
MTCH icon
193
Match Group
MTCH
$9.58B
$1.24M 0.13%
21,810
-11,296
-34% -$598K
WD icon
194
Walker & Dunlop
WD
$1.78B
$1.24M 0.13%
24,258
+3,006
+14% +$153K
FRPT icon
195
Freshpet
FRPT
$3.05B
$1.23M 0.12%
+29,115
New +$1.12M
SNBR
196
DELISTED
Sleep Number
SNBR
$1.23M 0.12%
+26,168
New +$1.05M
EVTC icon
197
Evertec
EVTC
$1.94B
$1.23M 0.12%
44,110
+13,792
+45% +$390K
IONS icon
198
Ionis Pharmaceuticals
IONS
$9.12B
$1.23M 0.12%
15,100
-2,800
-16% -$181K
WHD icon
199
Cactus
WHD
$5.3B
$1.23M 0.12%
34,404
-204
-0.6% -$6.95K
CVSA
200
Covista Inc
CVSA
$4.36B
$1.22M 0.12%
26,428
-8,625
-25% -$415K
6 7
8
9 10

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q1 2019 Portfolio in Review

As of Q1 2019, GSA Capital Partners held 1,870 positions worth $987M, up 14% from $867M the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

GSA Capital Partners deployed $63.5M of net new capital in Q1 2019, opening 579 new positions and adding to 363 existing holdings. Its largest new stake was DexCom: 187,420 shares worth $5.58M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Lumen, an estimated $7.13M trimmed.

  • GSA Capital Partners's largest Q1 2019 buy was DexCom: 187,420 shares worth $5.58M.
  • GSA Capital Partners added most to Biogen in Q1 2019, an estimated $6.71M increase.
  • GSA Capital Partners's biggest Q1 2019 reduction was Lumen, cutting an estimated $7.13M.
  • GSA Capital Partners fully exited Canada Goose Holdings in Q1 2019, selling an estimated $21.9M.
  • GSA Capital Partners's ten largest holdings make up 5.2% of its $987M portfolio in Q1 2019.
  • GSA Capital Partners opened 579 new positions and closed 480 in Q1 2019.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $987M.

Based on GSA Capital Partners's 13F filing for Q1 2019, filed 15 May 2019.